BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17889361)

  • 1. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients.
    Yoo KH; Lee SH; Kim HJ; Sung KW; Jung HL; Cho EJ; Park HK; Kim HA; Koo HH
    Bone Marrow Transplant; 2007 May; 39(9):515-21. PubMed ID: 17334379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.
    Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE
    Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
    Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncontrolled-rate freezing of peripheral blood progenitor cells allows successful engraftment by sparing primitive and committed hematopoietic progenitors.
    Almici C; Ferremi P; Lanfranchi A; Ferrari E; Verardi R; Marini M; Rossi G
    Haematologica; 2003 Dec; 88(12):1390-5. PubMed ID: 14687993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Mahmut N; Katayama Y; Takenaka K; Teshima T; Ohno Y; Imajyo K; Hara M; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Int J Hematol; 1999 Jan; 69(1):36-42. PubMed ID: 10641441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
    Allan DS; Dubé P; Roy J; Busque L; Roy DC
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
    Ozdemir E; Akgedik K; Akdogan S; Kansu E
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low numbers of megakaryocyte progenitors in grafts of cord blood cells may result in delayed platelet recovery after cord blood cell transplant.
    Kanamaru S; Kawano Y; Watanabe T; Nakagawa R; Suzuya H; Onishi T; Yamazaki J; Nakayama T; Kuroda Y; Takaue Y
    Stem Cells; 2000; 18(3):190-5. PubMed ID: 10840072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation.
    Yang H; Acker JP; Cabuhat M; McGann LE
    Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors.
    Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH
    Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation.
    Iori AP; Torelli GF; De Propris MS; Milano F; Pupella S; Gozzer M; Mancini F; Milani ML; Intoppa S; Cerretti R; Lucarelli B; Valle V; Malandruccolo L; Iannella E; Arleo E; Guarini A; Foà R
    Transplantation; 2008 Feb; 85(3):386-90. PubMed ID: 18322430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
    Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
    Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J
    Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of parameters affecting engraftment in children undergoing allogeneic BM transplants.
    Kletzel M; Haut PR; Olzewski M; Figuerres E
    Cytotherapy; 1999; 1(5):417-22. PubMed ID: 20443234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
    Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
    Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
    Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.